About this trial
The purpose of this study is to evaluate a new virtual reality (VR)-based rehabilitation program designed to help individuals with traumatic brain injury (TBI) improve their walking abilities in real-world settings. By comparing immersive VR-assisted overground gait therapy to contemporary non-immersive, treadmill-based VR therapy (i.e., C-Mill), the investigators aim to determine its effectiveness in enhancing mobility and quality of life for TBI patients.
Eligibility criteria
Qualifiers
Diagnosis: A confirmed diagnosis of traumatic brain injury (TBI), confirmed by the referring physician.
Cognitive Function: Mini-Mental State Examination (MMSE) score ≥ 24 or Montreal Cognitive Assessment (MoCA) score ≥ 20, indicating sufficient cognitive function to participate in the study.
Exercise Clearance: Approval from a physician for participation in exercise-based interventions.
Rehabilitation Need: Demonstrates a need for functional rehabilitation.
Disqualifiers
Participants with unstable medication regimens that could interfere with their participation in the study.
Any comorbidity that could interfere with walking or gait training.
Participation in VR-assisted gait training within the last 6 months.
Intolerance to virtual reality environments or motion simulation.
Trial design
Treatments tested in this trial
- C-Mill VR+ by Motek
- Walk-over-Ground
Treatment groups
Sponsors and collaborators
Indiana University
Lead sponsor
Indiana University Health
Collaborator